Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lumley

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Studies on the characterization of prostanoid receptorsI Kennedy, R A Coleman, P P Humphrey, et al.
European Journal of Pharmacology|July 16, 1982
Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dogP Lumley, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|February 1, 1991
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human plateletsI S Watts, K A Wharton, B P White, et al.
British Journal of Pharmacology|December 1, 1989
Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivoI S Watts, B P White, K A Wharton, et al.
British Journal of Pharmacology|July 1, 1981
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparationsR A Coleman, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|January 1, 1980
Are there two types of prostaglandin receptor mediating vasodilatation in the dog? [proceedings]R A Coleman, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|January 1, 1980
U-46619, a selective thromboxane A2-like agonist? [proceedings]R A Coleman, P P Humphrey, I Kennedy, et al.
Prostaglandins|November 1, 1982
Studies on the characterisation of prostanoid receptors: a proposed classificationI Kennedy, R A Coleman, P P Humphrey, et al.
Thrombosis and Haemostasis|November 30, 1990
A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in manI F Lane, P Lumley, M F Michael, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirinP Lumley, R J Keery, K A Wharton, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Studies on the characterization of prostanoid receptorsI Kennedy, R A Coleman, P P Humphrey, et al.
European Journal of Pharmacology|July 16, 1982
Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dogP Lumley, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|February 1, 1991
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human plateletsI S Watts, K A Wharton, B P White, et al.
British Journal of Pharmacology|December 1, 1989
Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivoI S Watts, B P White, K A Wharton, et al.
British Journal of Pharmacology|July 1, 1981
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparationsR A Coleman, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|January 1, 1980
Are there two types of prostaglandin receptor mediating vasodilatation in the dog? [proceedings]R A Coleman, P P Humphrey, I Kennedy, et al.
British Journal of Pharmacology|January 1, 1980
U-46619, a selective thromboxane A2-like agonist? [proceedings]R A Coleman, P P Humphrey, I Kennedy, et al.
Prostaglandins|November 1, 1982
Studies on the characterisation of prostanoid receptors: a proposed classificationI Kennedy, R A Coleman, P P Humphrey, et al.
Thrombosis and Haemostasis|November 30, 1990
A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in manI F Lane, P Lumley, M F Michael, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirinP Lumley, R J Keery, K A Wharton, et al.
Pageof 6